Patent US4096984A successfully refreshed from Google Patents.
Patent US5607417A successfully refreshed from Google Patents.
US5607417A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions and devices for controlled release of active ingredients
Assignee: CApHCO Inc
•
Filing: 1995-02-01
•
Granted: 1997-03-04
•
Expires: 2015-02-01
Abstract
Abstract A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with ureaseproducing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter. A ureteral catheter coated with a pH-sensitive polymer having an antibiotic or urease inhibitor trapped within its matrix will release the active agent when exposed to the high pH urine as the polymer gel swells. Such release can be made slow enough so that the drug remains at significant levels for a clinically useful period of time.
Inventors
- 👤 Christopher D. Batich
- 👤 Marc S. Cohen
- 👤 Kirk Foster
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 20:17
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027; A61L; A61L27/00; A61L27/28; A61L27/34; A61L27/50; A61L27/54; A61L29/00; A61L29/08; A61L29/085; A61L29/14; A61L29/16; A61L31/00; A61L31/14; A61L31/16; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/60; A61L2300/602; A61L2300/606
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
98 words
An indwelling medical device which controls, which indicates, or which both controls and indicates a bacterial infection which causes a change in the pH of the environment of said indwelling medical device, wherein said indwelling medical device comprises a pH-sensitive polymer matrix coating in which a biologically active agent is trapped and integrally incorporated, said agent being released from said polymer matrix coating at an increased rate or only upon said change of pH, wherein said change in pH causes said pH-sensitive polymer matrix to swell to release said biologically active agent trapped within said pH-sensitive polymer matrix.
Claim 2
Dependent Claim
98 words
An indwelling medical device which controls, which indicates, or which both controls and indicates a bacterial infection which causes a change in the pH of the environment of said indwelling medical device, wherein said indwelling medical device comprises a pH-sensitive polymer matrix coating in which a biologically active agent is trapped and integrally incorporated, said agent being released from said polymer matrix coating at an increased rate or only upon said change of pH, wherein said change in pH causes said pH-sensitive polymer matrix to swell to release said biologically active agent trapped within said pH-sensitive polymer matrix.
Claim 3
Dependent Claim
12 words
The device, according to claim 1, which is a catheter or stent.
Claim 4
Dependent Claim
13 words
The device of claim 1 wherein said biologically active agent is a dye.
Claim 5
Dependent Claim
15 words
The device, according to claim 1, wherein said pH-sensitive polymer comprises a weakly acidic monomer.
Claim 6
Dependent Claim
23 words
The device, according to claim 4, wherein said weakly acidic monomer is selected from the group consisting of methacrylic acid and acrylic acid.
Claim 7
Dependent Claim
26 words
The device, according to claim 4, wherein said pH-sensitive polymer further comprises a hydrophobic monomer selected from the group consisting of butylmethyl acrylate and methyl methacrylate.
Claim 8
Independent Claim
117 words
A method for controlling, indicating or both controlling and indicating a bacterial infection associated with the use of an indwelling medical device in an environment which is desired to be kept free of bacterial infection, wherein said infection causes or would cause a change in the pH of the environment of said indwelling medical device, wherein said method comprises; implanting into a patient an indwelling medical device, said device being coated with a pH-sensitive polymer matrix within which there is trapped and integrally incorporated a biologically active agent, wherein said polymer matrix swells to release said agent at an increased rate or only upon said change in pH, thereby indicating, controlling or indicating and controlling said infection.
Claim 9
Independent Claim
117 words
A method for controlling, indicating or both controlling and indicating a bacterial infection associated with the use of an indwelling medical device in an environment which is desired to be kept free of bacterial infection, wherein said infection causes or would cause a change in the pH of the environment of said indwelling medical device, wherein said method comprises; implanting into a patient an indwelling medical device, said device being coated with a pH-sensitive polymer matrix within which there is trapped and integrally incorporated a biologically active agent, wherein said polymer matrix swells to release said agent at an increased rate or only upon said change in pH, thereby indicating, controlling or indicating and controlling said infection.
Claim 10
Dependent Claim
13 words
The method of claim 7 wherein said biologically active agent is a dye.
Claim 11
Dependent Claim
34 words
The method, according to claim 7, further comprising selecting said medical device from the group consisting of ureteral or urethral catheters or stents, heart valves, pacemakers, artificial joints, gastrointestinal tubes, intrauterine devices, and diaphragms.
Claim 12
Dependent Claim
19 words
The method, according to claim 9, wherein said environment is urine and said pH is greater than about 8.5.
References Cited (Backward Citations)
US3067745A
Cited
US3861396A
Cited
EP0043319A1
Cited
EP0065884A1
Cited
US4743248A
Cited
US4999210A
Cited
US5165952A
Cited
US5152758A
Cited
EP0426486A2
Cited
US5120548A
Cited
US5261896A
Cited
WO1991016057A1
Cited
WO1992011877A1
Cited
US5217493A
Cited
WO1993025587A1
Cited
US5554147A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-03-03 | 2000-09-02 | 2001-03-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-03-03 | 2004-09-02 | 2005-03-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-03-03 | 2008-09-02 | 2009-03-04 | $7700.00 | Window Closed / Lapsed |